Abstract |
|
Authors | Daigoro Hirohama, Junichi Hoshino, Eiko Hasegawa, Masayuki Yamanouchi, Noriko Hayami, Tatsuya Suwabe, Naoki Sawa, Fumi Takemoto, Yoshifumi Ubara, Shigeko Hara, Kenichi Ohashi, Kenmei Takaichi |
Journal | Modern rheumatology
(Mod Rheumatol)
Vol. 20
Issue 6
Pg. 602-5
(Dec 2010)
ISSN: 1439-7609 [Electronic] England |
PMID | 20680377
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Antineutrophil Cytoplasmic
- Antibodies, Monoclonal
- Antirheumatic Agents
- Glucocorticoids
- Tumor Necrosis Factor-alpha
- Prednisolone
- Infliximab
- Peroxidase
- Methylprednisolone
|
Topics |
- Administration, Oral
- Adult
- Antibodies, Antineutrophil Cytoplasmic
(blood)
- Antibodies, Monoclonal
(adverse effects)
- Antirheumatic Agents
(adverse effects)
- Arthritis, Rheumatoid
(drug therapy)
- Drug Substitution
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Infliximab
- Injections, Intravenous
- Kidney
(blood supply, drug effects, immunology)
- Kidney Diseases
(chemically induced, immunology, pathology)
- Methylprednisolone
(therapeutic use)
- Peroxidase
(immunology)
- Prednisolone
(therapeutic use)
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
- Vasculitis
(chemically induced, immunology, pathology)
|